TEL : +44 (0) 1865 854 888EMAIL : email@example.com
Breath acetone prototype in for testing...
Arrangement with LighterLife...
First User Evaluation - breath acetone device...
OMD's technology featured in Reuters video...
View All News
Oxford Medical Diagnostics is currently developing a first generation OMD Breath AnalyserTM which applies proprietary Cavity Enhanced Absorption Spectroscopy technology to the quantitative detection of acetone in human breath. Initial applications centre on the rapid, cost-effective, and reliable non-invasive monitoring for fat-loss and diabetic ketoacidosis.
Ian Campbell Chief Executive Officer Oxford Medical Diagnostics Centre for Innovation & Enterprise Oxford University Begbroke Science Park Sandy Lane Yarnton Oxford OX5 1PF Tel: 01865 854888 Email: firstname.lastname@example.org
Tel: +44 (0) 1865 854 888 - email: email@example.com
Oxford Medical Diagnostics Ltd, Centre for Innovation & Enterprise, Begbroke Science Park, Begbroke Hill, Woodstock Road, Begbroke, OX5 1PF
Registered in England - Registered no. 06611677 - VAT No 935 9732 82
Content Management System By Fast Floor Multimedia